KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Equity Income (2016 - 2025)

Historic Equity Income for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $96.3 million.

  • Cme's Equity Income rose 1184.67% to $96.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $374.7 million, marking a year-over-year increase of 1476.26%. This contributed to the annual value of $350.9 million for FY2024, which is 1818.79% up from last year.
  • As of Q3 2025, Cme's Equity Income stood at $96.3 million, which was up 1184.67% from $99.0 million recorded in Q2 2025.
  • Cme's Equity Income's 5-year high stood at $99.0 million during Q2 2025, with a 5-year trough of $55.7 million in Q2 2021.
  • Moreover, its 5-year median value for Equity Income was $76.8 million (2023), whereas its average is $77.8 million.
  • Its Equity Income has fluctuated over the past 5 years, first skyrocketed by 5673.25% in 2022, then plummeted by 1397.48% in 2023.
  • Cme's Equity Income (Quarter) stood at $67.5 million in 2021, then decreased by 5.19% to $64.0 million in 2022, then rose by 4.38% to $66.8 million in 2023, then surged by 36.53% to $91.2 million in 2024, then increased by 5.59% to $96.3 million in 2025.
  • Its Equity Income was $96.3 million in Q3 2025, compared to $99.0 million in Q2 2025 and $88.2 million in Q1 2025.